Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/90185/000009018515000070/sial-20150331x10q.htm
November 2015
November 2015
November 2015
November 2015
November 2015
October 2015
July 2015
July 2015
June 2015
May 2015
• | Reported sales were $676 million compared to $689 million in the first quarter of 2014. Sales grew organically by 5%. Recent acquisitions increased sales by 1%. Changes in foreign currency exchange rates decreased sales by 8%. |
• | By business unit, organic sales growth was 3% in Research, 6% in Applied and 10% in SAFC Commercial. |
• | Reported diluted EPS was $1.04 compared to $1.05 in the first quarter of 2014. Adjusted diluted EPS (excluding $3 million of pre-tax merger-related costs) was $1.06, the same as in the first quarter of 2014. Changes in foreign currency exchange rates reduced first quarter 2015 adjusted EPS by $0.13. Excluding this impact, adjusted diluted EPS would have been $1.19, an increase of 12% from the same period last year. |
• | On May 5, the Company’s Board of Directors conditionally approved a quarterly cash dividend of $0.23 per share to shareholders of record on June 1, 2015. Payment of that dividend will be made on June 15, 2015 so long as the transaction by which Merck KGaA is to acquire all of the outstanding shares of the Company has not closed prior to that date. |
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/90185/000009018515000070/sial-20150331x10q.htm
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Sigma Aldrich Corp.
Sigma Aldrich Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2015 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Material Contracts, Statements, Certifications & more
Sigma Aldrich Corp provided additional information to their SEC Filing as exhibits
Ticker: SIAL
CIK: 90185
Form Type: 10-Q Quarterly Report
Accession Number: 0000090185-15-000070
Submitted to the SEC: Thu May 07 2015 9:48:19 AM EST
Accepted by the SEC: Thu May 07 2015
Period: Tuesday, March 31, 2015
Industry: Wholesale Chemicals And Allied Products